CLDI: Calidi Bio P/S multiplikatori

Calidi Bio (CLDI) brendining ramzi va logotipi

Biomateriallarning yuqori xarajatlari va ikkilamchi aksiyalar taklif qilish xavfi Calidi Biotherapeutics (CLDI) aksiyalari narxiga bosim o'tkazmoqda. Savdo daromadiga nisbatan narx ko'rsatkichi tendentsiyasi ushbu tebranishlarni vizuallashtiradi, bunda joriy metrika qiymatini tashkil etadi. Operatsion pul oqimining yetishmasligi va inersiya kapitali o'sishga to'sqinlik qilmoqda, shunga qaramay, kompaniyaning stam hujayralari dori yetkazib berish sohasidagi innovator sifatidagi maqomi onkologiyaga qarshi kurashda Calidi Biotherapeutics (CLDI) nufuzini mustahkamlaydi.

Calidi Bio - CLDI P/S multiplikatori (davr: 04.07.2022 - 13.11.2026)

Calidi Biotherapeutics (CLDI) kompaniyasining tahliliy kesimlari

- bozor narxi va tahlilchilarning maqsadli narxlari:
Aksiya kotirovkalari calidibio.com|CLDI - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi haqida ma'lumot:
Bozor kapitallashuvi Calidi Bio|CLDI - Kompaniyaning to‘liq qiymati
- balans bo'yicha xususiy kapital ma'lumotlari:
Bitta aksiya uchun sof aktivlar Calidi Biotherapeutics|CLDI - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi calidibio.com|CLDI - Kompaniyaning umumiy aktivlari
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati Calidi Biotherapeutics|CLDI - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti calidibio.com|CLDI - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Calidi Bio|CLDI - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzi Calidi Biotherapeutics|Oraliq qoplama koeffitsiyenti calidibio.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
CLDI - Kompaniyaning sof foydasi|Kutilayotgan sof foyda Calidi Biotherapeutics|CLDI - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning kelajakdagi foydaga nisbati calidibio.com|CLDI - PEG multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Calidi Bio|CLDI - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Calidi Biotherapeutics|CLDI - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi calidibio.com|CLDI - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Calidi Biotherapeutics
- emitentning tushumi va sotuvlari tafsilotlari:
CLDI - Kompaniya daromadi|Kompaniyaning kutilayotgan daromadi calidibio.com|CLDI - P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Calidi Bio
Kompaniyaning jamlanma tahliliyoti:Calidi Biotherapeutics Inc., CLDI
Calidi Biotherapeutics Inc. tomonidan chiqariladigan mahsulotlar

P/S koeffitsiyenti biznesning bozor qiymatini uning yillik daromadiga solishtiradi va bu generatsiya qilingan daromadning har bir birligi uchun to'langan premiumni baholash imkonini beradi. Barqaror savdolarsiz qimmat onkologik tadqiqotlarga e'tibor qaratgan Calidi Biotherapeutics (CLDI) uchun ushbu metrika spekulyativ kutishlarning ko'rsatkichi bo'lib xizmat qiladi, bu esa narx-savdo koeffitsiyentini kapitalning haddan tashqari yuqori baholanishi xavfining muhim belgisiga aylantiradi.

Raqobatdosh kompaniyalar

Kapitalizatsiyaning daromadga nisbati beigene.com ONC|P/S multiplikatori HALO (Halozyme)|P/S multiplikatori Revolution Medicines Inc RVMD|AAPG - Narxning daromadga nisbati|CGON: Narxning daromadga nisbati|URGN: P/S multiplikatori|BCAX - Narx/daromad koeffitsiyenti|PSNL (Personalis) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati ERAS (Erasca Inc)|P/S multiplikatori DCTH|Narx/daromad koeffitsiyenti Y-mAbs Corp|Aura Biosciences, Inc. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati CADL|Accuray - P/S multiplikatori|SLS: Narxning daromadga nisbati|ACTU: P/S multiplikatori|CTOR - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati TuHURA Biosciences Inc.|Sotuvga nisbatan narx protaratx.com TARA|Kapitalizatsiyaning daromadga nisbati FATE (Fate Therapeutics)|Kapitalizatsiyaning sotish hajmiga nisbati WHWK|P/S multiplikatori TCRX (TScan Therapeutics, Inc.)|Bozor kapitallashuvining daromadga nisbati CSBR|XBiotech USA - P/S multiplikatori|Sotuvga nisbatan narx CEL-SCI Corporation|OS Therapies (OSTX) - Narxning daromadga nisbati|radiopharmtheranostics.com - Bozor kapitallashuvining daromadga nisbati|ARTV (Artiva Biotherapeutics Inc.) - P/S multiplikatori|P/S multiplikatori Adlai Nortye Limited|Narxning daromadga nisbati Veru Inc. (VERU)|TPST: Narxning sotuvga nisbati|P/S multiplikatori XLO (Xilio Therapeutics)|Renovaro Biosciences (RENB) - Sotuvga nisbatan narx|MURA: Kapitalizatsiyaning daromadga nisbati|KAPA - P/S multiplikatori|OKUR (onkuretherapeutics.com) - Kapitalizatsiyaning daromadga nisbati|GDTC: Kapitalizatsiyaning sotish hajmiga nisbati|CRIS (Curis Inc.) - P/S multiplikatori|Apollomics Corp (APLM) - Narx/daromad koeffitsiyenti|P/S multiplikatori THAR|Kapitalizatsiyaning daromadga nisbati advanbiomed.com ADVB|Narxning daromadga nisbati Genprex, Inc. GNPX|Narx/daromad koeffitsiyenti sunshinebiopharma.com (SBFM)|Xenetic Bio - P/S multiplikatori|Salarius Pharmaceuticals Inc (SLRX) - Kapitalizatsiyaning daromadga nisbati|Purple Biotech Corp (PPBT) - Narxning daromadga nisbati|AONC (American Oncology Network, Inc.) - Narxning daromadga nisbati|BGNE (BeiGene, Ltd.) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati CKPT (checkpointtx.com)|P/S multiplikatori ELEV|Narx/daromad koeffitsiyenti icadmed.com|P/S multiplikatori IKNA (Ikena Oncology)|NTBL - Kapitalizatsiyaning daromadga nisbati|Viracta - P/S multiplikatori|MOR - P/S multiplikatori|NAYA Biosciences Inc. (NAYA) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati AAPGV